21. Housing Market Distortions and the Mortgage Interest Deduction. (September 2014) Authors: Hanson, Andrew; Martin, Hal Journal: Public finance review Issue: Volume 42:Number 5(2014:Sep.) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Lack of Clinically Relevant Effect of Bictegravir (BIC, B) on Metformin (MET) Pharmacokinetics (PK) and Pharmacodynamics (PD). (4th October 2017) Authors: Custodio, Joseph; West, Steve; Yu, Amanda; Martin, Hal; Graham, Hiba; Quirk, Erin; Kearney, Brian Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. LB4. A Phase 3, Randomized, Controlled Clinical Trial of Bictegravir in a Fixed-Dose Combination, B/F/TAF, vs. ABC/DTG/3TC in Treatment-Naïve Adults at Week 96. (26th November 2018) Authors: Wohl, David A; Yazdanpanah, Yazdan; Baumgarten, Axel; Clarke, Amanda; Thompson, Melanie; Brinson, Cynthia; Hagins, Debbie; Ramgopal, Moti; Antinori, Andrea; Wei, Xuelian; White, Kirsten; Collins, Sean; Cheng, Andrew; Quirk, Erin; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. P100 Tenofovir alafenamide (TAF) in a single tablet regimen in initial HIV-1 therapy. (18th May 2015) Authors: Pozniak, Anton; Wohl, David; Thompson, Melanie; DeJesus, Edwin; Podzamczer, Daniel; Molina, Jean Michel; Crofoot, Gordon; Callebaut, Christian; Martin, Hal; McCallister, Scott Journal: Sexually transmitted infections Issue: Volume 91(2015)Supplement 1 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. P176 Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir. (8th June 2017) Authors: Zhang, Heather; Custodio, Joseph; Wei, Xuelian; Wang, Hui; Wu, Amanda; Ling, John; Martin, Hal; Quirk, Erin; Elliott, Cindy; Kearney, Brian Journal: Sexually transmitted infections Issue: Volume 93(2017)Supplement 1 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results. (4th October 2017) Authors: Daar, Eric; DeJesus, Edwin; Ruane, Peter; Crofoot, Gordon; Oguchi, Godson; Creticos, Catherine; Rockstroh, Jurgen K; Molina, Jean-Michel; Koenig, Ellen; Liu, Ya-Pei; Andreatta, Kristen; Graham, Hiba; Cheng, Andrew; Martin, Hal; Quirk, Erin Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials. (15th May 2018) Authors: White, Kirsten; Garner, Will; Wei, Lilian; Eron, Joseph J.; Zhong, Lijie; Miller, Michael D.; Martin, Hal; Plummer, Andrew; Tran-Muchowski, Cecilia; Lindstrom, Kim; Porter, James; Piontkowsky, David; Light, Angela; Reiske, Heinz; Quirk, Erin Journal: AIDS Issue: Volume 32:Number 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus. (15th July 2020) Authors: Sax, Paul E; Rockstroh, Jürgen K; Luetkemeyer, Anne F; Yazdanpanah, Yazdan; Ward, Douglas; Trottier, Benoit; Rieger, Armin; Liu, Hui; Acosta, Rima; Collins, Sean E; Brainard, Diana M; Martin, Hal Journal: Clinical infectious diseases Issue: Volume 73:Number 2(2021) Page Start: e485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance. (1st November 2020) Authors: Acosta, Rima K.; Willkom, Madeleine; Andreatta, Kristen; Liu, Hui; Martin, Ross; Parvangada, Aiyappa; Martin, Hal; Collins, Sean; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study. (1st September 2021) Authors: Hagins, Debbie; Kumar, Princy; Saag, Michael; Wurapa, Anson K.; Brar, Indira; Berger, Daniel; Osiyemi, Olayemi; Hileman, Corrilynn O.; Ramgopal, Moti N.; McDonald, Cheryl; Blair, Christiana; Andreatta, Kristen; Collins, Sean E.; Brainard, Diana M.; Martin, Hal Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗